Intuitive Surgical EPS - Earnings per Share 2010-2024 | ISRG

Intuitive Surgical earnings per share (EPS) for the twelve months ending December 31, 2024 was $6.42, a 27.63% increase year-over-year.

  • Intuitive Surgical EPS for the quarter ending December 31, 2024 was $1.89, a 11.83% increase year-over-year.
  • Intuitive Surgical 2024 annual EPS was $6.42, a 27.63% increase from 2023.
  • Intuitive Surgical 2023 annual EPS was $5.03, a 37.81% increase from 2022.
  • Intuitive Surgical 2022 annual EPS was $3.65, a 21.67% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Intuitive Surgical EPS - Earnings per Share 2010-2024 | ISRG

  • Intuitive Surgical EPS for the quarter ending December 31, 2024 was $1.89, a 11.83% increase year-over-year.
  • Intuitive Surgical 2024 annual EPS was $6.42, a 27.63% increase from 2023.
  • Intuitive Surgical 2023 annual EPS was $5.03, a 37.81% increase from 2022.
  • Intuitive Surgical 2022 annual EPS was $3.65, a 21.67% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$203.1B
Alcon (ALC)$44.2B
Edwards Lifesciences (EW)$44B
IDEXX Laboratories (IDXX)$36.9B
DexCom (DXCM)$35B
IQVIA Holdings (IQV)$34.6B
Mettler-Toledo (MTD)$27.3B
Waters (WAT)$22.4B
STERIS (STE)$21.8B
SONOVA HOLDING (SONVY)$19.6B
Hologic (HOLX)$14.4B
Fresenius Medical Care AG KGaA (FMS)$13.6B
Penumbra (PEN)$11.7B
Sysmex ADR (SSMXY)$11.5B
Globus Medical (GMED)$11.5B
Masimo (MASI)$9.6B
Glaukos (GKOS)$8.9B
Teleflex (TFX)$8.1B
Integer Holdings (ITGR)$4.8B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.5B
Veracyte (VCYT)$3.3B
Nihon Kohden (NHNKY)$2.7B
TransMedics (TMDX)$2.7B
LivaNova (LIVN)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
Integra LifeSciences Holdings (IART)$1.7B
Alphatec Holdings (ATEC)$1.5B
Pulse Biosciences (PLSE)$1.2B